Finance

Beta
Lists
ATHE:NASDAQ
Alterity Therapeutics Ltd
$5.37
+9.82%
(+0.48) 1D
$5.42
+0.93% (+0.050)
Pre-market
Closed: Jun 30, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATHE...
Open
$4.90
High
$5.74
Low
$4.90
Mkt. cap
93.90M
Avg. vol.
77.45K
Volume
2.68K
52-wk high
$7.00
52-wk low
$2.69
EPS
-$0.01
Beta
0.33
Shares outstanding
18.13M
No. of employees
9
Open
$4.90
High
$5.74
Low
$4.90
Mkt. cap
93.90M
Avg. vol.
77.45K
Volume
2.68K
52-wk high
$7.00
52-wk low
$2.69
EPS
-$0.01
Beta
0.33
Shares outstanding
18.13M
No. of employees
9
News stories
From sources across the web
About Alterity Therapeutics Ltd
CEO-
Employees9
Founded1997
HeadquartersMelbourne, Victoria, Australia
SectorBiotechnology
Websitealteritytherapeutics.com
Analyst ratings
Based on 3 analysts giving stock ratings to ATHE in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ATHE in the last 3 months.
Highest
Current $5.37
$16.00 (+197.95%)
Average
$12.67 (+135.94%)
Lowest
$10.00 (+86.22%)
Analyst
Recommendation
Action
Price target
Projected
Date
Debanjana Chatterjee
JonesTrading
Buy
Maintained
$16.00
+198%
06/29/2026
Caroline Palomeque
Ladenburg Thalmann & Co.
Buy
Initiated
$10.00
+86.2%
06/16/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Initiated
$10.00
+86.2%
06/16/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
$12.00
+123.5%
06/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.92M
1.92M
1.40M
1.40M
Cost of goods sold
31.96K
31.96K
49.43K
49.43K
Cost of revenue
31.96K
31.96K
49.43K
49.43K
Research and development expenses
4.34M
4.34M
3.92M
3.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.25M
1.25M
2.56M
2.56M
Operating expense
5.44M
5.44M
6.57M
6.57M
Total operating expenses
5.48M
5.48M
6.62M
6.62M
Operating income
-3.56M
-3.56M
-5.22M
-5.22M
Other non operating income
-163.27K
-163.27K
-
-
EBT including unusual items
-2.45M
-2.45M
-4.78M
-4.78M
EBT excluding unusual items
-3.55M
-3.55M
-4.78M
-4.78M
Income tax expense
34.03K
34.03K
30.78K
30.78K
Effective tax rate
-1.39%
-1.39%
-0.64%
-0.64%
Other operating expenses
15.36K
15.36K
95.67K
95.67K
Net income
-2.49M
-2.49M
-4.81M
-4.81M
Net profit margin
-129.78%
-129.78%
-343.00%
-343.00%
Earnings per share
-
-
-
-
Interest and investment income
167.50K
167.50K
454.88K
454.88K
Interest expense
-
-
-
-
Net interest expenses
167.50K
167.50K
454.88K
454.88K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.55M
-3.55M
-5.22M
-5.22M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer